BioSpace

As H-1B visa changes keep coming, biopharmas adjust hiring approach

The $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the only program adjustment affecting foreign-born job seekers’ odds of working in the U.S.

By BioSpace

1 min read
As H-1B visa changes keep coming, biopharmas adjust hiring approach
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights